Cardiovascular / Cardiology
Vivasure Medical Announces FDA IDE Approval to Initiate U.S. Pivotal Study
Vivasure Medical® Limited (“Vivasure” or the “Company”), a company pioneering novel fully absorbable technology for percutaneous vessel closure, announced that the U.S. Food and Drug Administration (FDA) has granted an Investigational Device Exemption (IDE) to advance the company’s PATCH Clinical Study,...